Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
18.50 USD   +4.99%
09/27Stifel Adjusts Price Target on Deciphera Pharmaceuticals to $18 From $11, Reiterates Hold Rating
MT
09/12Piper Sandler Raises Deciphera Pharmaceuticals Price Target to $18 From $13, Maintains Neutral Rating
MT
09/12SVB Securities Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $21, Maintains Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about DECIPHERA PHARMACEUTICALS, INC.
09/27Stifel Adjusts Price Target on Deciphera Pharmaceuticals to $18 From $11, Reiterates Ho..
MT
09/12Piper Sandler Raises Deciphera Pharmaceuticals Price Target to $18 From $13, Maintains ..
MT
09/12SVB Securities Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $21, Maintai..
MT
09/12HC Wainwright Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $20, Reiterat..
MT
09/12Deciphera Pharmaceuticals, Inc. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
09/11Deciphera Pharmaceuticals, Inc. Presents Updated Phase 1/2 Data for Vimseltinib in TGCT..
BU
09/11Deciphera Pharmaceuticals, Inc. Presents Updated Phase 1/2 Data for Vimseltinib in TGCT..
CI
09/10Deciphera Pharmaceuticals, Inc. Presents Initial Phase 1 Single Agent Dose Escalation D..
BU
09/10Deciphera Pharmaceuticals, Inc. Presents Initial Phase 1 Single Agent Dose Escalation D..
CI
09/01Deciphera Pharmaceuticals, Inc. to Host Virtual Investor Event Featuring Key Opinion Le..
BU
08/29Deciphera Pharmaceuticals Shares Rise After Cowen Initiates Coverage
MT
08/29Cowen Starts Deciphera Pharmaceuticals at Outperform With $25 Price Target
MT
08/19Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5..
BU
08/10Deciphera Pharmaceuticals, Inc. Announces Publication of INTRIGUE Phase 3 Clinical Stud..
BU
08/10Deciphera Pharmaceuticals, Inc. Announces Publication of Intrigue Phase 3 Clinical Stud..
CI
08/05HC Wainwright Adjusts Price Target on Deciphera Pharmaceuticals to $20 From $15, Reiter..
MT
08/05JMP Securities Upgrades Deciphera Pharmaceuticals to Market Outperform From Market Perf..
MT
08/04Piper Sandler Adjusts Deciphera Pharmaceuticals Price Target to $13 From $11, Maintains..
MT
08/04Deciphera Pharmaceuticals' Q2 Loss Narrows, Revenue Rises
MT
08/04Transcript : Deciphera Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 04, ..
CI
08/04Deciphera Pharmaceuticals : Announces Second Quarter 2022 Financial Results - Form 8-K
PU
08/04DECIPHERA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Cond..
AQ
08/04Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q2 Revenue $32.5M
MT
08/04Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q2 Loss $-0.60
MT
08/04Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results
BU
08/04Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six..
CI
07/28Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and H..
BU
07/26Certain Unvested Restricted Stock Units of Deciphera Pharmaceuticals, Inc. are subject ..
CI
07/26Certain Stock Option of Deciphera Pharmaceuticals, Inc. are subject to a Lock-Up Agree..
CI
07/26Certain Common Stock of Deciphera Pharmaceuticals, Inc. are subject to a Lock-Up Agree..
CI
07/15Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5..
BU
06/24Deciphera Pharmaceuticals, Inc. : Submission of Matters to a Vote of Security Holders (for..
AQ
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/24Deciphera Pharmaceuticals, Inc.(NasdaqGS:DCPH) adde..
CI
06/16Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
BU
06/16Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Senior Vice President and Ch..
CI
06/02Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
BU
05/04Transcript : Deciphera Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, ..
CI
05/04DECIPHERA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Cond..
AQ
05/04Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Ma..
CI
05/04Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q1 Loss $-0.80, vs. Street Est of..
MT
05/04Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q1 Revenue $29.2M, vs. Street Est..
MT
05/04Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results
BU
05/02Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-..
AQ
05/02Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Con..
BU
04/29Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-..
BU
04/28Deciphera Pharmaceuticals, Inc. : Entry into a Material Definitive Agreement, Financial St..
AQ
04/27Deciphera Pharmaceuticals Prices $150 Million Public Offering
MT
04/27Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-..
BU
04/26Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Fu..
BU
04/26Deciphera Pharmaceuticals, Inc. : Results of Operations and Financial Condition, Other Eve..
AQ
04/13Truist Securities Adjusts Deciphera Pharmaceuticals' Price Target to $11 from $10, Keep..
MT
04/12Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR A..
BU
04/12Deciphera Pharmaceuticals, Inc Presents Preclinical Data from DCC-3116 Program At the A..
CI
04/11Sprint Bioscience presents preclinical VPS34 data at AACR 2022 Annual Meeting
AQ
03/16Transcript : Deciphera Pharmaceuticals, Inc. Presents at Barclays Global Heal..
CI
03/09Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
BU
03/04ICC faces "myriad challenges" to prosecute war crimes in Ukraine
RE
02/28Barclays Cuts Deciphera Pharmaceuticals to Underweight From Equalweight, Price Target t..
MT
02/15Analysis-Hints of compromise emerge over Mexico's contentious power bill
RE
02/11Deciphera Pharmaceuticals : EDITED TRANSCRIPT - Form 8-K
PU
02/09Clinigen Group plc Signs Distribution Agreement with Deciphera Pharmaceuticals
CI
02/08Deciphera Pharmaceuticals : Announces Fourth Quarter and Full Year 2021 Financial Results ..
PU
02/08Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended D..
CI
02/08Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended Decemb..
CI
02/08Transcript : Deciphera Pharmaceuticals, Inc., Q4 2021 Earnings Call, Feb 08, ..
CI
02/08Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Reports Q4 Revenue $24.2M, vs. Street E..
MT
02/08Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Reports Q4 Loss $-1.51, vs. Street Est ..
MT
02/08Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial R..
BU
02/02Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
BU
02/01Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Resul..
BU
1  2  3  4  5  6  7  8Next
Upcoming event on DECIPHERA PHARMACEUTICALS, INC.